• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical application of 2,5-DI-O-acetyl- -D-gluca ro- (1-4) (6-3)-dilactone (SLA) to the bladder tumor, with special reference to its effect on frequency of tumor recurrences.

作者信息

Ichikawa T

出版信息

J Urol. 1972 Oct;108(4):571-6. doi: 10.1016/s0022-5347(17)60805-x.

DOI:10.1016/s0022-5347(17)60805-x
PMID:4654258
Abstract
摘要

相似文献

1
Clinical application of 2,5-DI-O-acetyl- -D-gluca ro- (1-4) (6-3)-dilactone (SLA) to the bladder tumor, with special reference to its effect on frequency of tumor recurrences.
J Urol. 1972 Oct;108(4):571-6. doi: 10.1016/s0022-5347(17)60805-x.
2
[Clinical application of glucarolactone to bladder tumor. II. Effect of SLA on recurrence of bladder tumor].葡醛内酯在膀胱肿瘤中的临床应用。II. SLA对膀胱肿瘤复发的影响
Nihon Hinyokika Gakkai Zasshi. 1970 Oct;61(10):995-1003. doi: 10.5980/jpnjurol1928.61.10_995.
3
[Diacetyl-glucaro-(1 leads to 4) (6 leads to 3)-dilactone (SLA) for prevention of bladder tumor recurrence].用于预防膀胱肿瘤复发的二乙酰 - 葡萄糖醛酸 -（1→4）（6→3）- 二内酯（SLA）
Hinyokika Kiyo. 1970 Oct;16(10):586-92.
4
[A study of prophylaxis for recurrence of bladder tumor. Some statistical and experimental studies on the long term administration of -glucuronidase inhibitor (2,5-di-o-acetyl, D-glucaro(1-4)(6-3) dilactone) to patients of bladder tumor].
Nihon Hinyokika Gakkai Zasshi. 1972 Nov;63(11):951-71.
5
[Study of preventive effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU) or combination of HCFU and 2.5-di-O-acetyl-D-glucaro (1-4) (6-3) dilactone (SLA) after preservative operation against bladder cancer].
Hinyokika Kiyo. 1992 Jan;38(1):19-24.
6
Risk-adapted use of intravesical chemotherapy.膀胱内化疗的风险适应性应用。
BJU Int. 2008 Nov;102(9 Pt B):1247-53. doi: 10.1111/j.1464-410X.2008.07967.x.
7
[Preventive effect of beta-glucuronidase inhibitor (SLA) on recurrence of the bladder tumor].β-葡萄糖醛酸酶抑制剂（SLA）对膀胱肿瘤复发的预防作用
Hinyokika Kiyo. 1970 Dec;16(12):738-44.
8
Laser treatment of bladder cancer.
Semin Urol. 1985 Feb;3(1):2-9.
9
Intravesical chemotherapy.膀胱内化疗
Prog Clin Biol Res. 1984;162B:125-50.
10
Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.膀胱内化疗对复发性浅表性膀胱移行细胞癌复发率的影响：一项荟萃分析的结果
Anticancer Res. 2001 Jan-Feb;21(1B):765-9.

引用本文的文献

1
Glycosidases in cancer and invasion.癌症与侵袭中的糖苷酶
Cancer Metastasis Rev. 1985;4(1):81-101. doi: 10.1007/BF00047738.
2
Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C.
Cancer Chemother Pharmacol. 1987;20 Suppl:S77-80. doi: 10.1007/BF00262492.
3
A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.经尿道浅表性膀胱癌切除术后预防肿瘤复发的前瞻性随机研究——膀胱内注射噻替派与口服优福定对比
Cancer Chemother Pharmacol. 1992;30 Suppl:S26-30. doi: 10.1007/BF00686937.
4
Recurrence of superficial bladder tumours after transurethral resection.
Int Urol Nephrol. 1992;24(6):617-23. doi: 10.1007/BF02551297.